The combined analysis of 5 trials suggested STAT3/p-STAT3 overexpression in glioma was associated with worse PFS (HR = 2.05, 95%CI = 1.63 ~ 2.58, P < 0.001) (Figure 4(a)). Here, STAT3 is linked to central nervous system cancer.